Expired contract
NHS National Framework Agreement for Adalimumab Injection
Details
- Buyer
- NHS England
- Supplier(s)
- Value
- GBP 445,000,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 21 May 2020
- Source
- uk:contracts_finder
Tender description
NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Timeline
- Completed: Award date1 April 2020
- Completed: Award published21 May 2020Current notice
- Completed: Contract expiry date31 March 2022
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS National Framework Agreement for Adalimumab Injection.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
BuyersCountValue
- 461£2.1bn
- 374£250.3m
- 366£15.0bn
- 298£2.8bn
- 267£19.9bn
- 266£903.0m
- 255£517.2m
- 203£1.0bn
- 143£900.1m
- 135£63.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
